✦ LIBER ✦

Intervention thresholds for denosumab in the UK using a FRAX®-based cost-effectiveness analysis

✍ Scribed by O. Ström, B. Jönsson, J. A. Kanis

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

FRAX® and its applications in health eco

✍ O. Ström; F. Borgström; M. Kleman; E. McCloskey; A. Odén; H. Johansson; J.A. Kan 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 479 KB

The cost-effectiveness of risedronate in

✍ F. Borgström; O. Ström; J. Coelho; H. Johansson; A. Oden; E. V. McCloskey; J. A. 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 216 KB

PMS35 A Cost-Effectiveness Analysis of D

✍ K. Athanasakis; E. Karampli; M. Hollandezos; V. Papagiannopoulou; E. Badamgarav; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

Measuring activities in clinical trials

✍ Eugene Oddone; Morris Weinberger; Anita Hurder; William Henderson; David Simel 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 721 KB

Cost-effectiveness of a community-based

✍ Ndeffo Mbah, M. L.; Kjetland, E. F.; Atkins, K. E.; Poolman, E. M.; Orenstein, E 📂 Article 📅 2013 🏛 National Academy of Sciences 🌐 English ⚖ 577 KB

Liquid-based cervical cytology using Thi

✍ Esther W. de Bekker-Grob, Inge M. C. M. de Kok, Johan Bulten, Joost van Rosmalen 📂 Article 📅 2012 🏛 Springer Netherlands 🌐 English ⚖ 292 KB